These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 34995492)

  • 1. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.
    Giacomelli E; Vahsen BF; Calder EL; Xu Y; Scaber J; Gray E; Dafinca R; Talbot K; Studer L
    Cell Stem Cell; 2022 Jan; 29(1):11-35. PubMed ID: 34995492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis.
    Du H; Huo Z; Chen Y; Zhao Z; Meng F; Wang X; Liu S; Zhang H; Zhou F; Liu J; Zhang L; Zhou S; Guan Y; Wang X
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling ALS and FTD with iPSC-derived neurons.
    Lee S; Huang EJ
    Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
    Bohl D; Pochet R; Mitrecic D; Nicaise C
    Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model.
    Nizzardo M; Simone C; Rizzo F; Ruggieri M; Salani S; Riboldi G; Faravelli I; Zanetta C; Bresolin N; Comi GP; Corti S
    Hum Mol Genet; 2014 Jan; 23(2):342-54. PubMed ID: 24006477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS).
    Haidet-Phillips AM; Maragakis NJ
    Brain Res; 2015 Dec; 1628(Pt B):343-350. PubMed ID: 26187754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis.
    Okano H; Morimoto S; Kato C; Nakahara J; Takahashi S
    J Neurochem; 2023 Dec; 167(5):603-614. PubMed ID: 37952981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells.
    Guo W; Fumagalli L; Prior R; Van Den Bosch L
    Front Neurosci; 2017; 11():671. PubMed ID: 29326542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells in modeling and cell-based therapy of amyotrophic lateral sclerosis.
    Csobonyeiova M; Polak S; Nicodemou A; Danisovic L
    J Physiol Pharmacol; 2017 Oct; 68(5):649-657. PubMed ID: 29375039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.
    Rizzo F; Riboldi G; Salani S; Nizzardo M; Simone C; Corti S; Hedlund E
    Cell Mol Life Sci; 2014 Mar; 71(6):999-1015. PubMed ID: 24100629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique.
    Toli D; Buttigieg D; Blanchard S; Lemonnier T; Lamotte d'Incamps B; Bellouze S; Baillat G; Bohl D; Haase G
    Neurobiol Dis; 2015 Oct; 82():269-280. PubMed ID: 26107889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPSC-derived LewisX+CXCR4+β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models.
    Nizzardo M; Bucchia M; Ramirez A; Trombetta E; Bresolin N; Comi GP; Corti S
    Hum Mol Genet; 2016 Aug; 25(15):3152-3163. PubMed ID: 27270413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells from ALS patients for disease modeling.
    Richard JP; Maragakis NJ
    Brain Res; 2015 May; 1607():15-25. PubMed ID: 25223906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALS, a cellular whodunit on motor neuron degeneration.
    Karagiannis P; Inoue H
    Mol Cell Neurosci; 2020 Sep; 107():103524. PubMed ID: 32629110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and validation of human induced pluripotent stem cell line from sporadic amyotrophic lateral sclerosis (SALS).
    Ma J; Feng B; Kong D; He J; Guo R; Amponsah AE; Zhang W; Zhang S; Lv F; Song Y; Liu A; Cui H
    Stem Cell Res; 2020 Apr; 44():101760. PubMed ID: 32203916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis.
    Ziff OJ; Patani R
    Aging Cell; 2019 Feb; 18(1):e12862. PubMed ID: 30565851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
    Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
    Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
    Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
    Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.